Cloud DX and Medtronic Sign First Contract with Ontario Hospital

Cloud DX and Medtronic Sign First Contract with Ontario Hospital

Healthcare collaboration's first Remote Patient Monitoring deployment with St. Mary's General Hospital for Virtual COPD (Chronic Obstructive Pulmonary Disease) program

News in Summary

First joint deployment for Cloud DX and Medtronic since their announcement of a strategic collaboration
Hospital contract with St. Mary's General hospital in Kitchener, Ontario
Initial deployment to support Pulmonary Rehab, with growth into other practices in the hospital

Cloud DX (TSXV:CDX) (OTC:CDXFF), a leading Virtual Care platform, and its partner Medtronic Canada ULC, a subsidiary of global healthcare leader Medtronic plc (NYSE:MDT), signed their first joint Remote Patient Monitoring contract. The contract will support Virtual Care delivery at St. Mary's General Hospital, in Kitchener, Ontario, and will commence with an initial deployment for the hospital's COPD Activation Program. The program will support pulmonary COPD rehab patients with online education and rehab therapy sessions twice a week over a four-week period. The contract comes as Cloud DX gains recognition as a leader in providing pulmonary therapy support and reports multiple high satisfaction ratings

"We are pleased to announce this traction in our partnership with Cloud DX, the first of many contracts together. In our commitment to developing the virtual healthcare pathway, we are thrilled to work with Cloud DX and innovative hospitals, such as St. Mary's General Hospital," said Jessica Rudd, Director New Partnerships and Solutions at Medtronic Canada. "Virtual Care is a key component in the future of healthcare; it enhances many aspects of healthcare delivery from post-surgical support to at-home pulmonary rehab. It can bring patients and care teams closer together, improves patient outcomes, and helps to address our overloaded healthcare system. We look forward to supporting St. Mary's in delivering these benefits and growing our relationship together."

"Innovation is a priority at St. Mary's Hospital. Embracing new ways to deliver healthcare is important for our patients, staff, as well as the broader community. Innovations like Virtual Care delivery improves patient outcomes, and lowers hospitalization rates and re-admissions," added Sarah Farwell, Director, Strategy, Innovation and Communications at St. Mary's General Hospital. "As a direct result, it can alleviate burden on our hospital system, as well as help patients and their care teams better manage their condition and keep them well in the community. We anticipate these types of outcomes for patients of the pulmonary COPD rehab program, by partnering with our vendor of choice, Cloud DX and Medtronic. Patients love the easy-to-use technology. Our clinical team appreciates the thoughtfully developed clinician dashboard which eases workload and facilitates patient compliance. We're excited to be making strides in our goals to innovate healthcare, with healthtech leaders like Cloud DX and Medtronic."

"As a Kitchener based MedTech company, it is exciting to support a local hospital. With St. Mary's we will begin with the COPD Activation Program. This innovative program will offer online education and therapy sessions all via our Connected Health™ platform. It is clear this partnership between two renowned providers of healthcare services is an indication of things yet to come - especially when looking into how much more Virtual Care we can expect moving forward," said Robert Kaul, CEO and Founder of Cloud DX.

About Medtronic Canada ULC

Bold thinking. Bolder actions. We are Medtronic. Proud to serve Canadian healthcare for over 50 years, Medtronic Canada ULC is headquartered in Brampton, Ontario, with regional offices in Montreal and Vancouver, and is a subsidiary of Medtronic plc. We are the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 90,000+ passionate people. Our technologies and therapies address 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. In everything we do, we are engineering the extraordinary. Learn more at www.medtronic.ca.

About Cloud DX

Accelerating virtual healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health TM remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers." In 2021, Cloud DX became an exclusive partner to Medtronic Canada.

Cloud DX Investor Sitehttps://ir.clouddx.com/overview/default.aspx

About St. Mary's General Hospital:

Located in the heart of Kitchener, Ontario, St. Mary's known provincially and nationally as a leader in innovation, patient safety, and patient satisfaction. It is the second-largest acute care hospital in the St. Joseph's Health System and a Regional Cardiac Care and Thoracic Centre. St. Mary's proudly serves the residents of Waterloo, Wellington County, and extends its reach to Dufferin, Grey-Bruce and beyond.

St. Mary's is a Top 100 Forbes Canada's Top Employers with a dedicated, talented and passionate team of nearly 2,000 staff, physicians and volunteers. This team provides high-quality, compassionate care to hundreds of thousands of patients and families every year in our core areas of clinical focus:

  • Cardiac Care (Regional Cardiac Centre)
  • Respiratory Care (Level 1 Thoracic Surgery Centre)
  • Outpatient (Day) Surgery
  • General Medicine
  • 24/7 Emergency Care

Learn more about Our Mission, Values & History and the future of care at St. Mary's.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Social Links

Twitter https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
Instagram https://www.instagram.com/cloud.dx/

For media inquiries please contact:

Janine Scott Melicent Lavers
Marketing Lead Medtronic Canada Public Relations
888-543-0944 +1-905-460-3653
janine.scott@CloudDX.com

For investor inquiries please contact:

Jay Bedard Ryan Weispfenning
Cloud DX Investor Relations Medtronic plc Investor Relations
647-881-8418 +1-763-505-4626
jay.bedard@CloudDX.com

SOURCE: Cloud DX



View source version on accesswire.com:
https://www.accesswire.com/689912/Cloud-DX-and-Medtronic-Sign-First-Contract-with-Ontario-Hospital

News Provided by ACCESSWIRE via QuoteMedia

CDX:CA
The Conversation (0)
Cloud DX partners with Sheridan College on Medical Metaverse Research and Development

Cloud DX partners with Sheridan College on Medical Metaverse Research and Development

Developing the Clinic of the Future, Cloud DX work to be supported by Sheridan College through federal grant

News in Summary

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Cloud DX Signs Contract with Paramedical Service Provider for Remote Patient Monitoring

Cloud DX Signs Contract with Paramedical Service Provider for Remote Patient Monitoring

Cloud DX chosen as Virtual Care Platform for the Ontario Paramedical Service provider, replacing existing hardware and services

Cloud DX (TSXV:CDX)(OTCQX:CDXFF) is pleased to announce a new 24-month contract with an Ontario Paramedic Service Provider enabling the client to provide Remote Patient Monitoring (RPM) across its serviceable area. Cloud DX will provide its award-winning Connected Health™ platform and support the client as it transitions from its previous remote care tools to Cloud DX's Virtual Care Platform. The client showcases how beneficial ‘Remote Care Monitoring' is for Paramedical Service providers, enabling providers to establish deeper community roots and maintain funding levels, while community members benefit from greater access to much-needed care. The client has purchased 223 Connected Health™ kits totalling ~$145,000 CAD with additional recurring fees for subscription software services. Funding for the program comes from the $82.5M Community Paramedicine for Long-Term Care program announced by the Ontario government on October 22, 2021

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Cloud DX Signs Two Contracts with US Primary Care Clinics

Cloud DX Signs Two Contracts with US Primary Care Clinics

Continued growth in US RPM as partner Maxwell Telecare signs two additional clinics in Illinois

News in Summary

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Cloud DX Signs New Palliative Contract with Ontario Healthcare Team

Cloud DX Signs New Palliative Contract with Ontario Healthcare Team

Cloud DX Signs New Palliative Contract with Ontario Healthcare Team

Healthcare team to use Connected Health™ kits to provide dignity in care for up to 85 patients

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Cloud DX Announces Closing of Private Placement

Cloud DX Announces Closing of Private Placement

Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a leading North American provider of virtual care and Remote Patient Monitoring (RPM) solutions, is pleased to announce that it has closed a non-brokered private placement (the "Private Placement") of 260 units (the "Units") of the Corporation at a price of $1,000 per Unit, for gross proceeds of $260,000 (the "Offering"). Each Unit is comprised of (i) a C$1,000 principal amount unsecured convertible debenture (each, a "Debenture") and (ii) 1,430 common share purchase warrants of the Corporation (each, a "Warrant"). The Debentures will mature on January 27, 2025 (the "Maturity Date") and shall bear interest at a simple rate of 10% per annum. The principal amount of the Debentures may be converted at the election of the holder thereof into common shares in the capital of the Company ("Common Shares") at a conversion price of C$0.35 per Common Share (the "Conversion Price") at any time prior to the Maturity Date. Each Warrant entitles the holder thereof to acquire one common share of the Corporation (each, a "Common Share") at a price of C$0.50 per Common Share at any time prior to 4:30 p.m. (Toronto Time) on January 27, 2024

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is pleased to announce the establishment of its new Advisory Board. The Advisory Board will collaborate with management and the board of directors to enhance the Company's strategic direction, provide expert guidance on its commercial initiatives, offer industry insights, and shape and accelerate innovations.

As the inaugural member of the Advisory Board, Syntheia welcomes Mr. John Kirk, a leader in the travel industry. The travel sector represents a potentially significant growth market for the Company's technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is transforming customer service by delivering an innovative solution that uses natural language processing (NLP) to handle inbound telephone calls with virtual assistants. Since its beta launch in June 2023, Syntheia has processed over 750,000 conversations, bringing new levels of efficiency and engagement to businesses in diverse industries.

Companies like Georgetown Hyundai, Palmieri Furniture, Campio Furniture, and Pay N Go have all embraced Syntheia's platform, highlighting its positive impact on sales and customer satisfaction.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Zero Candida Technologies Inc.  Opens the Market

Zero Candida Technologies Inc. Opens the Market

Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the Company's new listing on the TSX Venture Exchange.

Zero Candida Technologies, Inc. (ZCT), is a medical device company bringing female healthcare into the 21st century. They are transforming the treatment of Vulvo-Vaginal Candidiasis ("VVC"), which affects 75% of women worldwide, often recurrent and increasingly drug-resistant with current treatments failing to address the root cause effectively. Free from chemicals and side effects, their AI-driven tampon-like device enables real-time data collection and transmission to physicians for personalized, at-home treatment. Beyond VVC, ZCT aims to revolutionize gynecology, improving access for underserved populations and advancing hybrid medicine.

Please refer to the Company's website here.

MEDIA CONTACT:
Victoria Gamble
Corporate Development Consultant
victoria@zero-candida.com
416-706-0332

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231280

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
XReality Group

xReality Group Limited Chairman’s Address 2024 Annual General Meeting – 22 November 2024

xReality Group Limited (ASX:XRG) (xReality) is pleased to present xReality Group Limited’s 2024 Annual General Meeting.

Keep reading...Show less
XReality Group

Operator XR – Sales Update November 24

xReality Group Limited (ASX:XRG) (xReality) is pleased to provide the following sales update for Operator XR, a wholly owned subsidiary of xReality Group Ltd. Operator XR provides Military and Law Enforcement agencies around the world with a unique, integrated Mission Planning & Rehearsal System, which is portable, secure, and highly immersive.

Keep reading...Show less
Syntheia Rings the Opening Bell on the Canadian Securities Exchange

Syntheia Rings the Opening Bell on the Canadian Securities Exchange

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, a Canadian leader in conversational AI, is pleased to announce that the Company's leadership team rang the bell to open the market in collaboration with the Canadian Securities Exchange to celebrate its successful listing under the symbol "SYAI".

" We look forward to great success through our partnership with the CSE as we commercially launch our conversational AI to the market. On behalf of the Company, I would like to thank everyone who has made this milestone happen, " commented Tony Di Benedetto, Chief Executive Officer at Syntheia.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×